Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Price to Book Value: 7.580 for June 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 04, 2024 | 7.580 |
| June 03, 2024 | 7.580 |
| May 31, 2024 | 7.569 |
| May 30, 2024 | 7.552 |
| May 29, 2024 | 7.531 |
| May 28, 2024 | 7.545 |
| May 24, 2024 | 7.555 |
| May 23, 2024 | 7.562 |
| May 22, 2024 | 7.569 |
| May 21, 2024 | 7.559 |
| May 20, 2024 | 7.573 |
| May 17, 2024 | 7.566 |
| May 16, 2024 | 7.548 |
| May 15, 2024 | 7.576 |
| May 14, 2024 | 7.538 |
| May 13, 2024 | 7.538 |
| May 10, 2024 | 7.555 |
| May 09, 2024 | 7.520 |
| May 08, 2024 | 7.527 |
| May 07, 2024 | 7.527 |
| May 06, 2024 | 7.534 |
| May 03, 2024 | 7.545 |
| May 02, 2024 | 7.559 |
| May 01, 2024 | 7.534 |
| April 30, 2024 | 7.538 |
| Date | Value |
|---|---|
| April 29, 2024 | 7.527 |
| April 26, 2024 | 7.517 |
| April 25, 2024 | 7.510 |
| April 24, 2024 | 7.510 |
| April 23, 2024 | 7.517 |
| April 22, 2024 | 7.482 |
| April 19, 2024 | 7.461 |
| April 18, 2024 | 7.457 |
| April 17, 2024 | 7.454 |
| April 16, 2024 | 7.461 |
| April 15, 2024 | 7.468 |
| April 12, 2024 | 7.478 |
| April 11, 2024 | 7.496 |
| April 10, 2024 | 7.496 |
| April 09, 2024 | 7.503 |
| April 08, 2024 | 7.510 |
| April 05, 2024 | 7.482 |
| April 04, 2024 | 7.520 |
| April 03, 2024 | 7.489 |
| April 02, 2024 | 7.471 |
| April 01, 2024 | 7.457 |
| March 28, 2024 | 8.116 |
| March 27, 2024 | 8.108 |
| March 26, 2024 | 8.108 |
| March 25, 2024 | 8.063 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4363
Minimum
Aug 11 2022
12.70
Maximum
Jun 29 2020
1.792
Average
1.397
Median
Sep 20 2021
Price to Book Value Benchmarks
| AstraZeneca PLC | 6.458 |
| Landos Biopharma Inc (DELISTED) | 3.096 |
| Acasti Pharma Inc | 0.4445 |
| Aurinia Pharmaceuticals Inc | 2.153 |
| Edesa Biotech Inc | 3.309 |
Price to Book Value Related Metrics
| PS Ratio | 713.16 |
| Price | 21.55 |
| Earnings Yield | -6.59% |
| Market Cap | 1.833B |